New cancer and weight loss drugs among six medicines approved for use in Scotland
Venetoclax has been given the go-ahead for patients with chronic lymphocytic leukaemia (CLL) by the Scottish Medicines Consortium - and will mean those diagnosed with the condition will not have to undergo chemotherapy.
Glasgow Live ·